Gabelli Funds’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Gabelli Funds’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-425,810	Closed	-$16M	–	1474
2021 Q1	$16M	Buy	+425,810	New	+$10.6M	0.11%	247

Gabelli Funds's FPRX Position: Q2 2021 in Review

Gabelli Funds sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 425,810 shares — an estimated $16M sold.

Gabelli Funds first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $16M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Gabelli Funds reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Gabelli Funds sold 425,810 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $16M.
Gabelli Funds first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Gabelli Funds's Five Prime Therapeutics, Inc. position peaked at $16M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Gabelli Funds's 13F filing for Q2 2021, filed 13 Aug 2021.